GB201610748D0 - Improved diffrentation method - Google Patents

Improved diffrentation method

Info

Publication number
GB201610748D0
GB201610748D0 GBGB1610748.4A GB201610748A GB201610748D0 GB 201610748 D0 GB201610748 D0 GB 201610748D0 GB 201610748 A GB201610748 A GB 201610748A GB 201610748 D0 GB201610748 D0 GB 201610748D0
Authority
GB
United Kingdom
Prior art keywords
diffrentation
improved
improved diffrentation
diffrentation method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1610748.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Netherlands Academy of Arts and Sciences
Original Assignee
Royal Netherlands Academy of Arts and Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Netherlands Academy of Arts and Sciences filed Critical Royal Netherlands Academy of Arts and Sciences
Priority to GBGB1610748.4A priority Critical patent/GB201610748D0/en
Publication of GB201610748D0 publication Critical patent/GB201610748D0/en
Priority to RU2018145539A priority patent/RU2772435C2/ru
Priority to AU2017281406A priority patent/AU2017281406B2/en
Priority to SG11201811405QA priority patent/SG11201811405QA/en
Priority to US16/310,933 priority patent/US20210047618A1/en
Priority to EP17732860.6A priority patent/EP3472302A1/en
Priority to BR112018076554-6A priority patent/BR112018076554B1/pt
Priority to KR1020197001809A priority patent/KR102478617B1/ko
Priority to KR1020227043758A priority patent/KR20230004913A/ko
Priority to JP2019518148A priority patent/JP7525263B2/ja
Priority to CA3030098A priority patent/CA3030098A1/en
Priority to CN201780047555.3A priority patent/CN109844098A/zh
Priority to PCT/EP2017/065101 priority patent/WO2017220586A1/en
Priority to MX2018016258A priority patent/MX2018016258A/es
Priority to MX2025004237A priority patent/MX2025004237A/es
Priority to IL263854A priority patent/IL263854A/en
Priority to JP2022024460A priority patent/JP2022068302A/ja
Priority to US18/918,172 priority patent/US20250145963A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0679—Cells of the gastro-intestinal tract
    • C12N5/068—Stem cells; Progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0679—Cells of the gastro-intestinal tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
GBGB1610748.4A 2016-06-20 2016-06-20 Improved diffrentation method Ceased GB201610748D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB1610748.4A GB201610748D0 (en) 2016-06-20 2016-06-20 Improved diffrentation method
MX2018016258A MX2018016258A (es) 2016-06-20 2017-06-20 Metodo de diferenciacion mejorada.
KR1020227043758A KR20230004913A (ko) 2016-06-20 2017-06-20 개선된 분화 방법
CA3030098A CA3030098A1 (en) 2016-06-20 2017-06-20 Improved differentiation method
SG11201811405QA SG11201811405QA (en) 2016-06-20 2017-06-20 Improved differentiation method
US16/310,933 US20210047618A1 (en) 2016-06-20 2017-06-20 Improved Differentiation Method
EP17732860.6A EP3472302A1 (en) 2016-06-20 2017-06-20 Improved differentiation method
BR112018076554-6A BR112018076554B1 (pt) 2016-06-20 2017-06-20 Método para diferenciar células progenitoras, meio de diferenciação, método para cultivar células-tronco epiteliais do intestino, estômago ou pâncreas, composição, e, uso de um organoide
KR1020197001809A KR102478617B1 (ko) 2016-06-20 2017-06-20 개선된 분화 방법
RU2018145539A RU2772435C2 (ru) 2016-06-20 2017-06-20 Улучшенный способ дифференцировки
JP2019518148A JP7525263B2 (ja) 2016-06-20 2017-06-20 改善された分化方法
AU2017281406A AU2017281406B2 (en) 2016-06-20 2017-06-20 Improved differentiation method
CN201780047555.3A CN109844098A (zh) 2016-06-20 2017-06-20 改进的分化方法
PCT/EP2017/065101 WO2017220586A1 (en) 2016-06-20 2017-06-20 Improved differentiation method
MX2025004237A MX2025004237A (es) 2016-06-20 2018-12-19 Metodo de diferenciacion mejorada
IL263854A IL263854A (en) 2016-06-20 2018-12-20 Improved methods of differentiation
JP2022024460A JP2022068302A (ja) 2016-06-20 2022-02-21 改善された分化方法
US18/918,172 US20250145963A1 (en) 2016-06-20 2024-10-17 Improved Differentiation Method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1610748.4A GB201610748D0 (en) 2016-06-20 2016-06-20 Improved diffrentation method

Publications (1)

Publication Number Publication Date
GB201610748D0 true GB201610748D0 (en) 2016-08-03

Family

ID=56895200

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1610748.4A Ceased GB201610748D0 (en) 2016-06-20 2016-06-20 Improved diffrentation method

Country Status (12)

Country Link
US (2) US20210047618A1 (enExample)
EP (1) EP3472302A1 (enExample)
JP (2) JP7525263B2 (enExample)
KR (2) KR102478617B1 (enExample)
CN (1) CN109844098A (enExample)
AU (1) AU2017281406B2 (enExample)
CA (1) CA3030098A1 (enExample)
GB (1) GB201610748D0 (enExample)
IL (1) IL263854A (enExample)
MX (2) MX2018016258A (enExample)
SG (1) SG11201811405QA (enExample)
WO (1) WO2017220586A1 (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
AU2012356133B2 (en) 2011-12-19 2018-07-26 Koninklijke Nederlandse Akademie Van Wetenschappen A rapid quantitative assay to measure CFTR function in a primary intestinal culture model
WO2015173425A1 (en) 2014-05-16 2015-11-19 Koninklijke Nederlandse Akademie Van Wetenschappen Improved culture method for organoids
ES2860423T3 (es) 2014-05-28 2021-10-05 Childrens Hospital Med Ct Métodos y sistemas para convertir células precursoras en tejidos gástricos mediante diferenciación dirigida
CA2963704A1 (en) 2014-10-17 2016-04-21 Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
GB201421092D0 (en) 2014-11-27 2015-01-14 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium
GB201421094D0 (en) 2014-11-27 2015-01-14 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium
GB201603569D0 (en) 2016-03-01 2016-04-13 Koninklijke Nederlandse Akademie Van Wetenschappen Improved differentiation method
CN109415685B (zh) 2016-05-05 2023-07-04 儿童医院医疗中心 用于体外制造胃底组织的方法和与其相关的组合物
SG10202104575WA (en) 2016-11-04 2021-06-29 Childrens Hospital Med Ct Liver organoid compositions and methods of making and using same
CA3045145A1 (en) 2016-12-05 2018-06-14 Children's Hospital Medical Center Colonic organoids and methods of making and using same
US12281334B2 (en) 2017-04-14 2025-04-22 Children's Hospital Medical Center Multi donor stem cell compositions and methods of making same
WO2019074793A1 (en) 2017-10-10 2019-04-18 Children's Hospital Medical Center OESOPHAGIAN TISSUE COMPOSITIONS AND / OR ORGANOIDS AND METHODS OF MAKING SAME
GB201721615D0 (en) 2017-12-21 2018-02-07 Koninklijke Nederlandse Akademie Van Wetenschappen Immune cell organoid co-cultures
US12379372B2 (en) 2017-12-21 2025-08-05 Children's Hospital Medical Center Digitalized human organoids and methods of using same
US11590152B2 (en) * 2018-01-26 2023-02-28 Massachusetts Eye And Ear Infirmary Treatment of hearing loss
CN110317775B (zh) * 2018-03-30 2022-06-10 中国科学院分子细胞科学卓越创新中心 用于肝细胞培养及肝脏类器官制备的培养基
JP2021522819A (ja) * 2018-05-07 2021-09-02 プレジデント アンド フェローズ オブ ハーバード カレッジ インビトロベータ細胞分化に関連する細胞集団および遺伝子発現
CA3106634A1 (en) 2018-07-26 2020-01-30 Children's Hospital Medical Center Hepato-biliary-pancreatic tissues and methods of making same
JP7377486B2 (ja) * 2018-09-10 2023-11-10 国立大学法人東京工業大学 多能性幹細胞から腸細胞の作製方法
CN112823012A (zh) 2018-09-12 2021-05-18 儿童医院医学中心 用于产生造血干细胞及其衍生物的类器官组合物
GB201819224D0 (en) 2018-11-26 2019-01-09 Koninklijke Nederlandse Akademie Van Wetenschappen Hepatocyte expansion methods
KR20200065892A (ko) 2018-11-30 2020-06-09 오가노이드사이언스 주식회사 오가노이드의 생체 이식용 조성물
KR102133693B1 (ko) * 2018-12-28 2020-07-13 서울대학교병원 타액선 유래 줄기세포를 타액선 조직으로 분화시키는 방법 및 구강 건조증 치료 또는 예방용 조성물
CN111500525B (zh) * 2019-01-30 2023-05-02 中国科学院广州生物医药与健康研究院 一种组合物及其应用
WO2020160371A1 (en) 2019-02-01 2020-08-06 The University Of Hong Kong Innervated organoid compositions and methods of making same
US12221630B2 (en) 2019-02-19 2025-02-11 Miltenyi Biotec B.V. & Co. KG Cell culture medium and method for generation of epithelial organoids from epithelial stem cells
US12584111B2 (en) 2019-02-26 2026-03-24 Peking University Compositions and methods for long term culture of hepatocytes
GB201906978D0 (en) 2019-05-17 2019-07-03 Koninklijke Nederlandse Akademie Van Wetenschappen Improved culture method using integrin agonist
CA3141807A1 (en) 2019-05-31 2020-12-03 Children's Hospital Medical Center Methods of generating and expanding hematopoietic stem cells
US12534709B2 (en) 2019-05-31 2026-01-27 Children's Hospital Medical Center Shaped organoid compositions and methods of making same
WO2021055565A1 (en) * 2019-09-17 2021-03-25 The Trustees Of Indiana University Prolonged function of liver organoids as an in vitro model for the study of liver disease
EP4048809B1 (en) 2019-10-22 2026-05-27 Tempus AI, Inc. Systems and methods for predicting therapeutic sensitivity
US11629385B2 (en) 2019-11-22 2023-04-18 Tempus Labs, Inc. Tumor organoid culture compositions, systems, and methods
KR102232244B1 (ko) * 2019-11-29 2021-03-24 고려대학교 산학협력단 Mhy1485 또는 이의 유도체를 포함하는 체세포로부터 유도만능줄기세포로의 역분화 효율 증진용 조성물 및 이를 이용한 역분화 효율 증진 방법
JP7744340B2 (ja) 2019-12-05 2025-09-25 テンパス・エーアイ・インコーポレイテッド ハイスループット薬物スクリーニングのためのシステムおよび方法
AU2020399785A1 (en) * 2019-12-12 2022-06-30 The Walter And Eliza Hall Institute Of Medical Research Organoid cultures
GB202004706D0 (en) 2020-03-31 2020-05-13 Koninklijke Nederlandse Akademie Van Wetenschappen Methods and tools for studying enteroendocrine cells
US11561178B2 (en) 2020-04-20 2023-01-24 Tempus Labs, Inc. Artificial fluorescent image systems and methods
WO2021254296A1 (zh) * 2020-06-14 2021-12-23 浙江大学 一种生物活性物质组合物、包含所述组合物的无血清培养基及其用途
US20220135950A1 (en) * 2020-11-03 2022-05-05 Korea Research Institute Of Bioscience And Biotechnology Human intestinal epithelium model and method for preparing same
WO2022152672A1 (en) 2021-01-12 2022-07-21 Astrazeneca Ab Graph construction and visualization of multiplex immunofluorescence images
EP4314256A1 (en) 2021-03-30 2024-02-07 Trailhead Biosystems Inc. Methods and compositions for generating oligodendrocyte progenitor cells
EP4329834A4 (en) * 2021-04-27 2025-08-13 Avita Medical Americas Llc REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES
CN113151152A (zh) * 2021-05-11 2021-07-23 中国人民解放军军事科学院军事医学研究院 一种小鼠肺类器官的培养方法及其专用培养液
WO2022241303A1 (en) * 2021-05-14 2022-11-17 University Of South Florida Composition and method for treating covid-19
CN113073080B (zh) * 2021-06-03 2021-08-13 北京科途医学科技有限公司 一种多形性横纹肌肉瘤类器官及其培养方法、培养基和用途
CN113403277B (zh) * 2021-06-28 2023-05-16 山东省第二人民医院(山东省耳鼻喉医院、山东省耳鼻喉研究所) 一种分离内耳fzd10阳性胶质细胞的方法
GB202109913D0 (en) 2021-07-09 2021-08-25 Stichting Hubrecht Organoid Tech Organoid-derived monolayers and uses thereof
JPWO2023074648A1 (enExample) * 2021-10-25 2023-05-04
AU2022375573A1 (en) * 2021-10-29 2024-05-23 Trailhead Biosystems Inc. Methods and compositions for generating human forebrain neural progenitor cells and for maturation thereof to parvalbumin+ interneurons
CN116694551A (zh) * 2022-02-24 2023-09-05 清华大学 诱导性成熟肝脏细胞及其制备的方法
WO2024112170A1 (ko) * 2022-11-24 2024-05-30 한국생명공학연구원 박막 코팅된 표면 위에서 장 줄기세포를 무이종 배양하는 법
CN116478912A (zh) 2023-06-07 2023-07-25 合肥工业大学 一种诱导小鼠肠道类器官定向分化为肠内分泌细胞的培养基及其应用
EP4495227A1 (en) 2023-07-18 2025-01-22 HUB Organoids IP B.V. Co-cultures of organoids and stromal cells
WO2025111693A1 (en) * 2023-11-30 2025-06-05 University Health Network Generation of enterochromaffin and pancreatic cells
KR20250087176A (ko) * 2023-12-07 2025-06-16 한국화학연구원 역분화 줄기세포 유래 염증성 장 질환 모델, 이의 제조 방법 및 이를 이용한 약물 효능 평가 방법
WO2026006723A1 (en) * 2024-06-27 2026-01-02 Anand Rene Reagents and methods for treating headache and migraine pain and co-morbidities thereof
EP4779306A1 (en) 2025-01-17 2026-07-22 HUB Organoids IP B.V. Co-cultures of organoids, stromal cells and immune cells
CN119931962B (zh) * 2025-04-07 2025-08-05 北京华诺泰生物医药科技有限公司 一种人偏肺病毒的培养方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642339B2 (en) * 2009-02-03 2014-02-04 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
WO2013061608A1 (ja) * 2011-10-27 2013-05-02 国立大学法人東京医科歯科大学 大腸上皮幹細胞の単離・培養技術と、これを用いた大腸上皮移植技術
CN105121632B (zh) * 2013-02-18 2021-08-10 大学健康网络 由多能干细胞生成肝细胞和胆管细胞的方法
BR112015023261A2 (pt) * 2013-03-14 2017-07-18 Massachusetts Inst Technology composições e métodos para expansão e cultura de células-tronco epiteliais
CA2985344A1 (en) 2014-06-26 2015-12-30 The Trustees Of Columbia University In The City Of New York Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
CA3010610A1 (en) 2016-01-08 2017-07-13 The Brigham And Women's Hospital, Inc. Production of differentiated enteroendocrine cells and insulin producing cells

Also Published As

Publication number Publication date
JP2022068302A (ja) 2022-05-09
AU2017281406B2 (en) 2022-07-14
KR20190028443A (ko) 2019-03-18
BR112018076554A2 (pt) 2019-04-02
RU2018145539A3 (enExample) 2021-03-19
EP3472302A1 (en) 2019-04-24
KR102478617B1 (ko) 2022-12-19
MX2018016258A (es) 2019-05-20
US20250145963A1 (en) 2025-05-08
SG11201811405QA (en) 2019-01-30
RU2018145539A (ru) 2020-07-21
IL263854A (en) 2019-02-03
AU2017281406A1 (en) 2019-01-17
CA3030098A1 (en) 2017-12-28
CN109844098A (zh) 2019-06-04
JP7525263B2 (ja) 2024-07-30
JP2019527068A (ja) 2019-09-26
KR20230004913A (ko) 2023-01-06
US20210047618A1 (en) 2021-02-18
MX2025004237A (es) 2025-05-02
WO2017220586A1 (en) 2017-12-28

Similar Documents

Publication Publication Date Title
GB201607521D0 (en) Method
GB201609221D0 (en) Method
GB201609220D0 (en) Method
GB201602394D0 (en) Method
GB201601773D0 (en) Method
GB201603367D0 (en) Method
GB201608918D0 (en) Method
GB201518918D0 (en) Method
GB201608403D0 (en) Method
GB201601120D0 (en) Eye-testing method
GB201608969D0 (en) Method
GB201607572D0 (en) Alyklation method
GB201602927D0 (en) Method
GB201608848D0 (en) Method
GB201608806D0 (en) Method
GB201608660D0 (en) Method
GB201608658D0 (en) Method
GB201608469D0 (en) Method
GB201607828D0 (en) Method
GB201607463D0 (en) Method
GB201604898D0 (en) Method
GB201604620D0 (en) Method
GB201604572D0 (en) Method
GB201604291D0 (en) Method
GB201604204D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)